Emendo Biotherapeutics

DNA Correction and Genome-editing Platforms

Startup

Emendo Biotherapeutics is a -based startup in the Health Tech & Life Sciences sector, established in 2015. DNA Correction and Genome-editing Platforms. The company has raised a total of $73M across 2 funding rounds, currently at the Acquired stage. Emendo Biotherapeutics was founded by Lior Izhar. Key investors include OrbiMed, Takeda Ventures. The company has 11-50 employees. Core technologies: Biologicals, Genes.

With $73M in total funding, Emendo Biotherapeutics is a Acquired-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent. Emendo Biotherapeutics has been acquired.

$73M
Raised
2
Rounds
2
Investors
3
Team
2015
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiologicalsGenes
At a Glance
Investors
Founders
In the News

8 articles covered by sources including www.calcalistech.com, www.themarker.com, www.businesswire.com, www.vivebiotech.com, en.globes.co.il.

www.calcalistech.com · Dec 20, 2023
AnGes laying off 110 EmendoBio employees three years after $250 million acquisition | CTech
Read article ↗
Frequently Asked Questions
What does Emendo Biotherapeutics do?

Emendo Biotherapeutics develops next-generation gene-editing tools for genetic disorders, addressing technological gaps for realizing the promise of gene therapy. Emendo genome-editing technology can repair and eliminate genetic mutations in living cells that cause serious diseases or disorders. Emendo's gene-editing solutions are recombination based, highly specific, and have zero off-target effect.

How much funding has Emendo Biotherapeutics raised?

Emendo Biotherapeutics has raised $73M in total funding across 2 rounds. The company is currently at the Acquired stage. Key investors include OrbiMed, Takeda Ventures.

Who founded Emendo Biotherapeutics?

Emendo Biotherapeutics was founded in 2015 by Lior Izhar (Co-founder & CTO).

What sector is Emendo Biotherapeutics in?

Emendo Biotherapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Genes. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology, Pharmaceuticals.

Where is Emendo Biotherapeutics located?

Emendo Biotherapeutics is based in Ilan Ramon Street 2, Ness Ziona, Israel. The company also has offices abroad.

View Full Profile Classic View Website ↗